Dr Ian Nisbet, Chief Operating Officer and co-founder of Cartherics, brings over three decades of biotech leadership exp...
The BIO International Convention, the world’s largest and most comprehensive event for the biotechnology indu...
South Korea-based Samsung Biologics, a leading contract development and manufacturing organisation (CDMO), has announced...
MGI Tech Co., Ltd., and Asia Pathogen Genomics Initiative (Asia PGI), part of the Duke-NUS Centre for Outbreak Preparedn...
Singapore-based biopharmaceutical company Specialised Therapeutics (ST) has expanded its existing supply and d...
Syensqo, a global leader in advanced materials and specialty chemicals, has announced the inauguration of its world clas...
Indian startup GenepoweRx, a trailblazer in artificial intelligence (AI)-powered personalised medicine based on gen...
AriBio Co., a South Korean biopharmaceutical company specialising in neurodegenerative diseases, and a Swiss pharmaceuti...
A research team led by Associate Professor Yoshinori Yoshida and Specially Appointed Assistant Professor Yuya ...
China-based startup Qure Biotechnology (Shanghai) has completed a Series C1 financing round. The financing raised nearly...
Fujirebio, a leading innovator in in-vitro diagnostics, has announced a collaboration with Stanford Medicine, ...
AusBiotech, Australia’s peak body for the life sciences sector, and the Australian Government's Trade and Investme...
US-based startup Elpis Biopharmaceuticals, a clinical-stage cell therapy company developing bispecific armored CAR-...
BioNet, a Franco-Thai vaccine biotech group, and PT Bio Farma (Persero), Indonesia's state-owned vaccine manuf...
MarkHerz Inc., a South Korea-based biotechnology startup specialising in AAV-based gene therapies targeting cardiovascul...
To accelerate clinical trial activation and execution, enhance research quality, and strengthen international competitiv...
Australia-based PolyActiva, a clinical-stage biopharmaceutical company pioneering a novel drug delivery technology to im...
French pharmaceutical company Sanofi and Blueprint Medicines Corporation, a US-based, publicly traded biopharmaceutical ...
